ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $3,945,000 | +5.8% | 81,398 | -7.8% | 0.80% | -34.7% |
Q1 2020 | $3,729,000 | -28.9% | 88,266 | -28.0% | 1.23% | -11.5% |
Q4 2019 | $5,243,000 | +35.5% | 122,551 | +14.0% | 1.39% | +10.2% |
Q3 2019 | $3,870,000 | +245.8% | 107,525 | +156.9% | 1.26% | +246.7% |
Q2 2019 | $1,119,000 | -60.9% | 41,860 | -60.7% | 0.36% | -64.1% |
Q1 2019 | $2,860,000 | +613.2% | 106,535 | +762.3% | 1.01% | +67.4% |
Q2 2016 | $401,000 | -61.8% | 12,355 | -67.1% | 0.60% | -51.4% |
Q1 2016 | $1,050,000 | +105.9% | 37,570 | +162.9% | 1.24% | +132.1% |
Q4 2015 | $510,000 | -19.6% | 14,293 | -25.5% | 0.54% | -6.1% |
Q3 2015 | $634,000 | -66.0% | 19,185 | -56.9% | 0.57% | -57.5% |
Q2 2015 | $1,863,000 | -6.5% | 44,476 | -27.2% | 1.34% | +18.3% |
Q1 2015 | $1,992,000 | -51.7% | 61,118 | -52.9% | 1.14% | -44.9% |
Q4 2014 | $4,121,000 | +60.7% | 129,791 | +25.3% | 2.06% | +59.9% |
Q3 2014 | $2,564,000 | +164.6% | 103,550 | +167.2% | 1.29% | +216.7% |
Q4 2013 | $969,000 | -46.8% | 38,760 | -41.6% | 0.41% | -51.0% |
Q3 2013 | $1,823,000 | – | 66,355 | – | 0.83% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
First Washington CORP | 176,950 | $3,976,000 | 2.06% |
SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |